Renerva’s main focus is to develop and commercialize implantable technologies to improve the outcome of peripheral nerve repair procedures. The company is committed to developing the next generation of surgical solutions to improve peripheral nerve repair, accelerate healing following a nerve injury, and improve nerve function following injury and repair.
Pitt Startup Hits a Nerve for New CEO
Employees: 1-10
Total raised: $2.4M
Founded date: 2017
Investors 3
| Date | Name | Website |
| - | University... | innovation... |
| - | Cowtown An... | cowtownang... |
| 30.08.2022 | Kevin M. M... | mcgovernce... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 14.12.2018 | - | $2.4M | - |
Mentions in press and media 1
| Date | Title | Description | Source |
| 14.12.2018 | Renerva lands $2.4 million to develop ‘Neosporin of nerve re... | Nerve-repair startup Renerva said today it has received $2.4 million in funding from the U.S. Depart... | massdevice... |